However, high expression of IDO1 in HCC has also been shown to positively correlate with the number of CD8+ T cells, which indicates the presence of an anti‐tumour immune response, suggesting that IDO1 may be a favourable prognostic indicator for patients with HCC. This evidence concerns the gene CD8A and hepatocellular carcinoma.